Reducing elevated intraocular pressure in conditions such as ocular hypertension and chronic open-angle glaucoma.
Combination therapy working on two different mechanisms by increasing aqueous humor fluid uveoscleral outflow by 50% and decrease excessive production of aqueous humor fluid.
Maintains a 24 hour consistent IOP control.
Maximum effectiveness with additional reductions in IOP more than monotherapy.
One drop in the affected eye(s) once a day.